Hemojuvelin mediated hepcidin induction requires both bone morphogenetic protein type I receptors ALK2 and ALK3.
Dogan DY, Urzica EI, Hornung I, Kastl P, Oguama D, Fette FM, Nguyen LH, Rosenbauer F, Zacharowski K, Klingmüller U, Gradhand E, von Knethen A, Popp R, Fleming I, Schrader L, Steinbicker AU.
Dogan DY, et al.
Blood Adv. 2024 Apr 8:bloodadvances.2023012322. doi: 10.1182/bloodadvances.2023012322. Online ahead of print.
Blood Adv. 2024.
PMID: 38588481